Note: sources that have an asterisk require login to view the article.
In Case You Missed It!
IMPORTANT: CMMI seeking a clinical pharmacist as part of the Seamless Care Models Group
DH Announcement (Direct Hire – Open to all U.S. Citizens):
Announcement number: CMS-CMMI-22-11350740-DE
Title, Series, Grade: Pharmacist, GS-0660-14
Close date: Tuesday, February 8, 2022
This position is being announced by the CMS Center for Medicare and Medicaid Innovation (CMMI), Seamless Care Models Group (SCMG).
*You will lose consideration for the position if you do not submit the required documentation with your application. Please reference the Required Documents section in the announcement for further information.
- Lead the design, development, implementation of innovative Part D pharmaceutical models with payment or service-delivery implications.
- Provide recommendations to leadership on implementing innovative pharmaceutical payment models that improve access to critically needed drugs with a reduction in out-of-pocket costs for beneficiaries and reduce federal government spending.
- Lead CMS coordination with national professional organizations, private insurers, and pharmaceutical industry representatives on innovative pharmaceutical payment and care models.
- Translate the results of Medicare Part D pricing studies into actionable policy and program recommendations that inform CMS Medicare Part D policies and processes with consideration of policy impacts, economic viability and technical feasibility.
- Lead interpretation and analysis of pharmacy administrative claims and plan-reported data concerning drug coverage, pharmacy services and drug utilization patterns.
SEE THE EVIDENCE | The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs
Learn about the peer-reviewed evidence showcasing the value of CMM, through improvements in access to care, provider work life, outcomes and patient satisfaction as well as a reduction in costs. These findings, updated in December 2021, outline the CMM team-based care process that can be implemented in a variety of health care systems to ensure positive patient outcomes.
SEE THE GUIDANCE | The Integration of Telehealth Delivery within a Comprehensive Medication Management Practice
Considering the advantages of telehealth and the future direction of health care, it is no longer a question of if telehealth needs to be implemented into practice; rather, it is a question of how to integrate telehealth and CMM services. Core to a plan is a patient care team that works together to achieve a goal of enhancing patient-centered care and medication optimization. Outlined are essential steps to integrating telehealth services and CMM practice: define what telehealth means for your practice, secure stakeholders, develop a team, equipment and software needs; assess costs and financial stability, educate staff, patients and caregivers, develop a workflow, measure health care outcomes and meet with your team regularly.
SEE THE GUIDANCE | Value Framework for Providing CMM in Telehealth
The escalation of telehealth has shed light on the opportunities that exist to increase patient access to care through virtual visits that extend beyond the traditional in-office visit. Included as an opportunity for telehealth is comprehensive medication management (CMM). This value framework, intended for health care team members, payers for health care services and health care policy makers, proposes a guide for providing CMM services via telehealth. Although obstacles to telehealth delivery of CMM exist, the benefits to providers, patients and payers outweigh the barriers. For sustainability of telehealth and CMM provided via telehealth, effort from multiple stakeholders is needed to address the challenges that exist.
Join us to be part of meaningful change
Irma, like many others, struggles as a result of our current trial-and-error approach to medication. That is why we advocate for a new, comprehensive approach to medication use and prescribing. As a non-profit 501(c)(3) and 501(c)(4) organization, the GTMRx Institute and Foundation relies on funding from our supporting members. We ask that you consider becoming a Supporting Signing Member so we can continue to provide relevant, timely resources to get the medications right!
If you’re interested in supporting the Institute or Foundation at a higher level, please contact us. Your dollars will bring about meaningful change for people like Irma.
Become a Supporting Member Today